March 29, 2017
TroutTalks KOL Series: 2nd Annual AACR Preview Event
New York, United States
The Trout Group to Host Wall Street Unplugged Panel at the 2016 New York BIO Annual Conference
May 5, 2016
Panel to Take Place on May 12, 2016 at 8:30AM; Panel Led by Trout, Featuring CFOs / Investors / Analysts
NEW YORK, NY -- (Marketwired) -- 05/05/16 --
The Trout Group, the leading global investor relations and strategic advisory firm servicing the life sciences industry, will host a panel at the 2016 New York BIO Annual Conference, entitled "Wall Street Unplugged: Management's Guide to Wall Street and the Capital Markets" on May 12, 2016 from 8:30AM to 9:30AM ET at the Time Warner Center in New York City. The panel of investors, analysts, bankers and executives will provide input on the current market environment, accessing capital, and perspectives on communicating with the biotech investment community.
Lee M. Stern, CFA, Managing Director at Trout will moderate the panel. The panel members are:
- Tony Gibney, Managing Director, Leerink Partners
- Josh Riegelhaupt, Ph.D., Therapeutics Analyst, Baron Funds
- Alan S. Roemer, SVP, Finance & Operations, Roivant Sciences
- Gur Roshwalb, MD, MBA, Chief Executive Officer, Akari Therapeutics
- Joshua Schimmer, MD, Senior Research Analyst, Piper Jaffray
- Yaron Werber, MD, Chief Financial Officer, Ovid Therapeutics
This event is open to all registrants of the 2016 New York BIO Annual Conference. To register, please visit http://www.newyorkbio.org.
About The Trout Group
The Trout Group is a global investor relations and strategic advisory firm. Since 1996, Trout has been a leading strategic partner to the life sciences industry, connecting companies, the capital markets and innovations in the sector. Trout's unique suite of services at the intersection of scientific advances and a network of institutional relationships creates long term value for stakeholders.
Lee M. Stern, CFA
+1 (646) 378-2922
Source: The Trout Group LLC